Skip to content

Effects of ferulic acid, gamma-oryzanol, and an exercise program on cognitive function in healthy older adults

Study on the synergistic effects of oral intake of ferulic acid and gamma-oryzanol from rice bran components and an exercise program on cognitive function in older adults - Ferulic acid, gamma-oryzanol, and exercise study for cognitive function in older adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061111
Enrollment
200
Registered
2026-04-01
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related decline in cognitive function and health maintenance in healthy older adults

Interventions

Arm A: Non-exercise plus placebo capsule group. Participants orally take 4 placebo soft capsules daily for 12 weeks. No specific exercise program is provided, and participants continue their usual dai

Sponsors

Wakayama University
Lead Sponsor
Tsuno Rice Fine Chemicals Co., Ltd.
Collaborator
Koyasan University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy men and women aged 60 to 84 years 2. Individuals judged healthy based on a medical interview or examination by a physician 3. Individuals not using medications or supplements expected to influence the study outcomes 4. Individuals who receive a full explanation of the study, understand the study, and can provide written informed consent 5. Individuals who are able to attend the scheduled visits and undergo the required assessments 6. Individuals judged eligible for participation by a physician

Exclusion criteria

Exclusion criteria: 1. Individuals judged unsuitable for participation by a physician 2. Individuals unable to attend the scheduled visits 3. Individuals using medications or supplements expected to influence the study outcomes 4. Individuals unable to understand the study or provide written informed consent 5. Individuals not cleared for participation in the exercise component based on the pre-study medical check-up

Design outcomes

Primary

MeasureTime frame
Changes in cognitive function assessed by Cognitrax. The primary evaluation focuses on changes from baseline to week 12. Assessments are performed at baseline, week 6, week 12, and 6 months after the end of intake.

Secondary

MeasureTime frame
Changes in subjective cognitive status assessed by the Visual Analogue Scale (VAS), physical fitness measures, anthropometric measures, blood pressure, blood biochemical parameters, and health questionnaire outcomes will be evaluated. Blood tests are performed only at baseline and after 12 weeks.

Countries

Japan

Contacts

Public ContactMitsugi Motoyama

Wakayama University Wakayama University Headquarters

motoyama@wakayama-u.ac.jp073-457-7309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026